Susi Roger E.

Susi Roger E., chairman, president, and CEO of IRadimed Corporation (IRMD), has sold stock consistently through the spring of 2026. His Form 4 filings show 25 open-market sales between May 4 and June 1, with no purchases in that window. The combined value of those recent transactions is roughly $2.5 million, with individual trades ranging from a $531 sale on May 19 to a $301,444 sale on May 18. The pattern is one-directional. Across his entire filing history, Susi has recorded 117 transactions in IRMD, all in a single company. His total sell value is $17,983,522.90, and his total buy value is zero. He has also reported no acquisitions through grants or option exercises in the recent period, which means the sales are reducing his direct holdings rather than converting compensation into cash. The recent trades cluster on specific dates, often with multiple sales on the same day. On May 18, for example, he filed three separate sales totaling $437,571. On May 26, two sales added up to $461,165. The June 1 batch included four sales worth $226,507. The dollar amounts vary widely, from the small $531 trade to six-figure blocks, but the direction is uniform: every recent Form 4 with code S is a sale, and there is no code P activity to offset it.